Compile Data Set for Download or QSAR
Report error Found 13 Enz. Inhib. hit(s) with all data for entry = 12516
TargetLactoperoxidase(Human)
Esgelbio

US Patent
LigandPNGBDBM707363(US20240408072, Compound NE-2-6)
Affinity DataIC50: 13nMAssay Description:The screening of compounds for MPO inhibition activity was conducted in three stages. The inhibitory activity of each compound against MPO was assess...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/23/2025
Entry Details
US Patent

TargetLactoperoxidase(Human)
Esgelbio

US Patent
LigandPNGBDBM707365(US20240408072, Compound NE-2-8)
Affinity DataIC50: 16nMAssay Description:The screening of compounds for MPO inhibition activity was conducted in three stages. The inhibitory activity of each compound against MPO was assess...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/23/2025
Entry Details
US Patent

TargetLactoperoxidase(Human)
Esgelbio

US Patent
LigandPNGBDBM707364(US20240408072, Compound NE-2-7)
Affinity DataIC50: 20nMAssay Description:The screening of compounds for MPO inhibition activity was conducted in three stages. The inhibitory activity of each compound against MPO was assess...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/23/2025
Entry Details
US Patent

TargetLactoperoxidase(Human)
Esgelbio

US Patent
LigandPNGBDBM50133597(CHEBI:8502 | Propacil | Propylthiouracil | Prothyr...)
Affinity DataIC50: 119nMAssay Description:The screening of compounds for MPO inhibition activity was conducted in three stages. The inhibitory activity of each compound against MPO was assess...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2025
Entry Details
US Patent

TargetLactoperoxidase(Human)
Esgelbio

US Patent
LigandPNGBDBM707366(US20240408072, Compound NE-2-9)
Affinity DataIC50: 130nMAssay Description:The screening of compounds for MPO inhibition activity was conducted in three stages. The inhibitory activity of each compound against MPO was assess...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/23/2025
Entry Details
US Patent

TargetMyeloperoxidase(Human)
Esgelbio

US Patent
LigandPNGBDBM707365(US20240408072, Compound NE-2-8)
Affinity DataIC50: 770nMAssay Description:The screening of compounds for MPO inhibition activity was conducted in three stages. The inhibitory activity of each compound against MPO was assess...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/23/2025
Entry Details
US Patent

TargetThyroid peroxidase(Human)
Esgelbio

US Patent
LigandPNGBDBM707363(US20240408072, Compound NE-2-6)
Affinity DataIC50: 890nMAssay Description:The screening of compounds for MPO inhibition activity was conducted in three stages. The inhibitory activity of each compound against MPO was assess...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/23/2025
Entry Details
US Patent

TargetThyroid peroxidase(Human)
Esgelbio

US Patent
LigandPNGBDBM707365(US20240408072, Compound NE-2-8)
Affinity DataIC50: 1.05E+3nMAssay Description:The screening of compounds for MPO inhibition activity was conducted in three stages. The inhibitory activity of each compound against MPO was assess...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/23/2025
Entry Details
US Patent

TargetMyeloperoxidase(Human)
Esgelbio

US Patent
LigandPNGBDBM707364(US20240408072, Compound NE-2-7)
Affinity DataIC50: 1.50E+3nMAssay Description:The screening of compounds for MPO inhibition activity was conducted in three stages. The inhibitory activity of each compound against MPO was assess...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/23/2025
Entry Details
US Patent

TargetMyeloperoxidase(Human)
Esgelbio

US Patent
LigandPNGBDBM707366(US20240408072, Compound NE-2-9)
Affinity DataIC50: 1.83E+3nMAssay Description:The screening of compounds for MPO inhibition activity was conducted in three stages. The inhibitory activity of each compound against MPO was assess...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/23/2025
Entry Details
US Patent

TargetThyroid peroxidase(Human)
Esgelbio

US Patent
LigandPNGBDBM707364(US20240408072, Compound NE-2-7)
Affinity DataIC50: 2.25E+3nMAssay Description:The screening of compounds for MPO inhibition activity was conducted in three stages. The inhibitory activity of each compound against MPO was assess...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/23/2025
Entry Details
US Patent

TargetMyeloperoxidase(Human)
Esgelbio

US Patent
LigandPNGBDBM50133597(CHEBI:8502 | Propacil | Propylthiouracil | Prothyr...)
Affinity DataIC50: 5.50E+3nMAssay Description:The screening of compounds for MPO inhibition activity was conducted in three stages. The inhibitory activity of each compound against MPO was assess...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2025
Entry Details
US Patent

TargetMyeloperoxidase(Human)
Esgelbio

US Patent
LigandPNGBDBM707363(US20240408072, Compound NE-2-6)
Affinity DataIC50: 6.45E+3nMAssay Description:The screening of compounds for MPO inhibition activity was conducted in three stages. The inhibitory activity of each compound against MPO was assess...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
4/23/2025
Entry Details
US Patent